| Period Ending: |
LTM
(Last Twelve Months) |
2021 12-31 |
2020 12-31 |
|---|---|---|---|
| Report Filing | 2022-08-15 | 2022-04-07 | 2021-03-25 |
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 3.47 | 2.09 | 0 |
| Gross Profit | -3.47 | -2.09 | 0 |
| Operating Expenses | -0.403 | 0 | 0.176 |
| Research & Development | 0 | 0 | 0 |
| Selling, General and Administrative | -0.402 | 0 | 0 |
| Other Operating Expenses | -0.001 | 0 | 0.176 |
| Operating Income | -3.07 | -2.09 | -0.176 |
| Net Non-Operating Interest | 2.89 | 0.017 | 0 |
| Interest Income | 0.025 | 0.017 | 0 |
| Interest Expense | -2.86 | 0 | 0 |
| Equity & Other Income/(Expense) | 17.2 | 11.66 | 0 |
| Income Before Tax | 17.02 | 9.59 | -0.176 |
| Income Tax Expense | -13.06 | -11.68 | 0 |
| Income Attributable to Non-Controlling Interest | 0.001 | 0 | 0 |
| Net Income | 30.08 | 21.27 | -0.176 |
| Depreciation and Amortization | 15.99 | 11.68 | 0.206 |
| EBITDA | 12.93 | 9.59 | 0.03 |
| Earnings Per Share (EPS) | 1 | 0.68 | -0.006 |
| Diluted Earnings Per Share | 1.4 | 0.68 | -0.006 |
| Weighted Average Shares Outstanding | 25 | 31.25 | 31.25 |
| Diluted Weighted Average Shares Outstanding | 25 | 31.25 | 31.25 |
